Get access

Examining Braak's hypothesis by imaging Parkinson's disease

Authors

  • David J. Brooks MD, DSc, FRCP, FMed Sci

    Corresponding author
    1. MRC Clinical Sciences Centre and Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom
    • Imperial College London, Cyclotron Building, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
    Search for more papers by this author

  • Potential conflict of interest: None.

Abstract

In this review, in vivo patterns of structural, metabolic, and neurotransmitter binding changes revealed by imaging in both symptomatic Parkinson's disease (PD) and at-risk subjects are compared with those predicted at different Braak stages. It is concluded that the dysfunction revealed by imaging in PD is only partially in line with the sequential ascending topography of Lewy body pathology reported by Braak, suggesting that neurons in different brain regions are likely to be selectively vulnerable to the presence of intracellular synuclein aggregates. © 2010 Movement Disorder Society

Ancillary